AMERIMMUNE PHARMACEUTICALS INC
10KSB40, EX-27, 2000-06-29
BLANK CHECKS
Previous: AMERIMMUNE PHARMACEUTICALS INC, 10KSB40, EX-10.6, 2000-06-29
Next: GALAXY FOODS CO, 10-K, 2000-06-29



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the
registrant's Form 10-KSB for the Fiscal Year ended March 31, 2000
and is qualified in its entirety to such form.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                         522,649
<SECURITIES>                                   618,360
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,178,935
<PP&E>                                          35,075
<DEPRECIATION>                                  11,600
<TOTAL-ASSETS>                               1,205,450
<CURRENT-LIABILITIES>                          225,139
<BONDS>                                              0
                                0
                                          0
<COMMON>                                     2,152,143
<OTHER-SE>                                   2,933,277
<TOTAL-LIABILITY-AND-EQUITY>                 1,205,450
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,912,260
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,592
<INCOME-PRETAX>                            (1,920,852)
<INCOME-TAX>                                     1,600
<INCOME-CONTINUING>                        (1,922,452)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,922,452)
<EPS-BASIC>                                     (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission